ID LAMB2_MOUSE Reviewed; 1799 AA. AC Q61292; Q62182; Q8R0Y0; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 27-MAR-2024, entry version 184. DE RecName: Full=Laminin subunit beta-2; DE AltName: Full=Laminin-11 subunit beta; DE AltName: Full=Laminin-14 subunit beta; DE AltName: Full=Laminin-15 subunit beta; DE AltName: Full=Laminin-3 subunit beta; DE AltName: Full=Laminin-4 subunit beta; DE AltName: Full=Laminin-7 subunit beta; DE AltName: Full=Laminin-9 subunit beta; DE AltName: Full=S-laminin subunit beta; DE Short=S-LAM beta; DE Flags: Precursor; GN Name=Lamb2; Synonyms=Lams; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=129/J; RX PubMed=8662701; DOI=10.1074/jbc.271.23.13407; RA Durkin M.E., Gautam M., Loechel S., Sanes J.R., Merlie J.P., RA Albrechtsen R., Wewer U.M.; RT "Structural organization of the human and mouse laminin beta2 chain genes, RT and alternative splicing at the 5' end of the human transcript."; RL J. Biol. Chem. 271:13407-13416(1996). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 348-428. RC TISSUE=Lung; RX PubMed=8043959; DOI=10.1007/bf00356563; RA Aberdam D., Galliano M.-F., Mattei M.-G., Ortonne J.-P., Meneguzzi G.; RT "S-laminin gene (Lams) maps to F1 band of mouse chromosome 9."; RL Mamm. Genome 5:393-394(1994). RN [5] RP FUNCTION. RC STRAIN=129/J; RX PubMed=7885444; DOI=10.1038/374258a0; RA Noakes P.G., Gautam M., Mudd J., Sanes J.R., Merlie J.P.; RT "Aberrant differentiation of neuromuscular junctions in mice lacking s- RT laminin/laminin beta 2."; RL Nature 374:258-262(1995). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Pancreas, RC Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Binding to cells via a high affinity receptor, laminin is CC thought to mediate the attachment, migration and organization of cells CC into tissues during embryonic development by interacting with other CC extracellular matrix components. {ECO:0000269|PubMed:7885444}. CC -!- FUNCTION: Laminin-3 (S-laminin) regulates the formation of motor nerve CC terminals. {ECO:0000269|PubMed:7885444}. CC -!- SUBUNIT: Laminin is a complex glycoprotein, consisting of three CC different polypeptide chains (alpha, beta, gamma), which are bound to CC each other by disulfide bonds into a cross-shaped molecule comprising CC one long and three short arms with globules at each end. Beta-2 is a CC subunit of laminin-3 (laminin-121 or S-laminin), laminin-4 (laminin-221 CC or S-merosin), laminin-7 (laminin-321 or KS-laminin), laminin-9 CC (laminin-421), laminin-11 (laminin-521), laminin-14 (laminin-423) and CC laminin-15 (laminin-523). CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix, basement membrane. CC -!- TISSUE SPECIFICITY: Neuromuscular synapse and kidney glomerulus. CC -!- DOMAIN: The alpha-helical domains I and II are thought to interact with CC other laminin chains to form a coiled coil structure. CC -!- DOMAIN: Domains VI and IV are globular. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U43541; AAC53535.1; -; Genomic_DNA. DR EMBL; U42624; AAC53535.1; JOINED; Genomic_DNA. DR EMBL; CH466560; EDL21291.1; -; Genomic_DNA. DR EMBL; CH466560; EDL21292.1; -; Genomic_DNA. DR EMBL; BC026051; AAH26051.1; -; mRNA. DR EMBL; X75928; CAA53532.1; -; mRNA. DR CCDS; CCDS23528.1; -. DR PIR; I48749; I48749. DR RefSeq; NP_032509.2; NM_008483.3. DR RefSeq; XP_006511711.1; XM_006511648.2. DR AlphaFoldDB; Q61292; -. DR SMR; Q61292; -. DR BioGRID; 201102; 9. DR ComplexPortal; CPX-3010; Laminin-121 complex. DR ComplexPortal; CPX-3011; Laminin-221 complex. DR ComplexPortal; CPX-3014; Laminin-321 complex. DR ComplexPortal; CPX-3017; Laminin-521 complex. DR ComplexPortal; CPX-3019; Laminin-423 complex. DR ComplexPortal; CPX-3020; Laminin-522 complex. DR ComplexPortal; CPX-3021; Laminin-523 complex. DR ComplexPortal; CPX-3031; Laminin-421 complex. DR IntAct; Q61292; 1. DR MINT; Q61292; -. DR STRING; 10090.ENSMUSP00000069087; -. DR GlyConnect; 2460; 8 N-Linked glycans (1 site). DR GlyCosmos; Q61292; 7 sites, 7 glycans. DR GlyGen; Q61292; 8 sites, 7 N-linked glycans (1 site), 1 O-linked glycan (1 site). DR iPTMnet; Q61292; -. DR PhosphoSitePlus; Q61292; -. DR SwissPalm; Q61292; -. DR MaxQB; Q61292; -. DR PaxDb; 10090-ENSMUSP00000069087; -. DR PeptideAtlas; Q61292; -. DR ProteomicsDB; 263696; -. DR Pumba; Q61292; -. DR Antibodypedia; 995; 428 antibodies from 30 providers. DR DNASU; 16779; -. DR Ensembl; ENSMUST00000065014.10; ENSMUSP00000069087.5; ENSMUSG00000052911.10. DR GeneID; 16779; -. DR KEGG; mmu:16779; -. DR UCSC; uc009rpr.2; mouse. DR AGR; MGI:99916; -. DR CTD; 3913; -. DR MGI; MGI:99916; Lamb2. DR VEuPathDB; HostDB:ENSMUSG00000052911; -. DR eggNOG; KOG0994; Eukaryota. DR GeneTree; ENSGT00940000156060; -. DR HOGENOM; CLU_001560_1_0_1; -. DR InParanoid; Q61292; -. DR OMA; SCRDHTG; -. DR OrthoDB; 90222at2759; -. DR PhylomeDB; Q61292; -. DR TreeFam; TF312903; -. DR BioGRID-ORCS; 16779; 1 hit in 76 CRISPR screens. DR ChiTaRS; Lamb2; mouse. DR PRO; PR:Q61292; -. DR Proteomes; UP000000589; Chromosome 9. DR RNAct; Q61292; Protein. DR Bgee; ENSMUSG00000052911; Expressed in humerus cartilage element and 254 other cell types or tissues. DR ExpressionAtlas; Q61292; baseline and differential. DR GO; GO:0005604; C:basement membrane; IDA:UniProtKB. DR GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0043256; C:laminin complex; IDA:MGI. DR GO; GO:0005608; C:laminin-3 complex; IDA:MGI. DR GO; GO:0031594; C:neuromuscular junction; IDA:SynGO. DR GO; GO:0098637; C:protein complex involved in cell-matrix adhesion; NAS:ComplexPortal. DR GO; GO:0045202; C:synapse; IDA:MGI. DR GO; GO:0043083; C:synaptic cleft; IDA:SynGO. DR GO; GO:0005178; F:integrin binding; IPI:MGI. DR GO; GO:0150043; F:structural constituent of synapse-associated extracellular matrix; IDA:SynGO. DR GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central. DR GO; GO:0014002; P:astrocyte development; IGI:MGI. DR GO; GO:0048677; P:axon extension involved in regeneration; IMP:MGI. DR GO; GO:0007411; P:axon guidance; IGI:MGI. DR GO; GO:0070831; P:basement membrane assembly; IBA:GO_Central. DR GO; GO:0016477; P:cell migration; IBA:GO_Central. DR GO; GO:0000902; P:cell morphogenesis; IGI:MGI. DR GO; GO:0072274; P:metanephric glomerular basement membrane development; IMP:MGI. DR GO; GO:0072249; P:metanephric podocyte development; IMP:MGI. DR GO; GO:0007528; P:neuromuscular junction development; IMP:MGI. DR GO; GO:0031175; P:neuron projection development; IDA:MGI. DR GO; GO:0045785; P:positive regulation of cell adhesion; NAS:ComplexPortal. DR GO; GO:2001046; P:positive regulation of integrin-mediated signaling pathway; NAS:ComplexPortal. DR GO; GO:0051149; P:positive regulation of muscle cell differentiation; NAS:ComplexPortal. DR GO; GO:0110011; P:regulation of basement membrane organization; NAS:ComplexPortal. DR GO; GO:0060041; P:retina development in camera-type eye; IGI:MGI. DR GO; GO:0014044; P:Schwann cell development; IDA:MGI. DR GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IBA:GO_Central. DR GO; GO:0050808; P:synapse organization; IMP:MGI. DR GO; GO:0009888; P:tissue development; IBA:GO_Central. DR GO; GO:0007601; P:visual perception; IGI:MGI. DR CDD; cd22299; cc_LAMB2_C; 1. DR CDD; cd00055; EGF_Lam; 13. DR Gene3D; 2.60.120.260; Galactose-binding domain-like; 1. DR Gene3D; 2.10.25.10; Laminin; 9. DR Gene3D; 2.170.300.10; Tie2 ligand-binding domain superfamily; 2. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR013015; Laminin_IV_B. DR InterPro; IPR008211; Laminin_N. DR InterPro; IPR002049; LE_dom. DR PANTHER; PTHR10574:SF435; LAMININ SUBUNIT GAMMA-1; 1. DR PANTHER; PTHR10574; NETRIN/LAMININ-RELATED; 1. DR Pfam; PF00053; Laminin_EGF; 13. DR Pfam; PF21199; LAMININ_IV_B; 1. DR Pfam; PF00055; Laminin_N; 1. DR PRINTS; PR00011; EGFLAMININ. DR SMART; SM00181; EGF; 8. DR SMART; SM00180; EGF_Lam; 13. DR SMART; SM00136; LamNT; 1. DR SUPFAM; SSF57196; EGF/Laminin; 13. DR PROSITE; PS00022; EGF_1; 10. DR PROSITE; PS01186; EGF_2; 2. DR PROSITE; PS01248; EGF_LAM_1; 12. DR PROSITE; PS50027; EGF_LAM_2; 13. DR PROSITE; PS51116; LAMININ_IVB; 1. DR PROSITE; PS51117; LAMININ_NTER; 1. DR Genevisible; Q61292; MM. PE 1: Evidence at protein level; KW Basement membrane; Cell adhesion; Coiled coil; Disulfide bond; KW Extracellular matrix; Glycoprotein; Laminin EGF-like domain; KW Phosphoprotein; Reference proteome; Repeat; Secreted; Signal. FT SIGNAL 1..35 FT /evidence="ECO:0000255" FT CHAIN 36..1799 FT /note="Laminin subunit beta-2" FT /id="PRO_0000017069" FT DOMAIN 46..285 FT /note="Laminin N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00466" FT DOMAIN 286..349 FT /note="Laminin EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 350..412 FT /note="Laminin EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 413..472 FT /note="Laminin EGF-like 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 473..524 FT /note="Laminin EGF-like 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 525..555 FT /note="Laminin EGF-like 5; truncated" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 564..778 FT /note="Laminin IV type B" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00462" FT DOMAIN 784..831 FT /note="Laminin EGF-like 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 832..877 FT /note="Laminin EGF-like 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 878..927 FT /note="Laminin EGF-like 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 928..986 FT /note="Laminin EGF-like 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 987..1038 FT /note="Laminin EGF-like 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1039..1095 FT /note="Laminin EGF-like 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1096..1143 FT /note="Laminin EGF-like 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1144..1190 FT /note="Laminin EGF-like 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT REGION 1191..1410 FT /note="Domain II" FT REGION 1339..1365 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1411..1443 FT /note="Domain alpha" FT REGION 1444..1799 FT /note="Domain I" FT REGION 1679..1701 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 1257..1304 FT /evidence="ECO:0000255" FT COILED 1473..1527 FT /evidence="ECO:0000255" FT COILED 1577..1791 FT /evidence="ECO:0000255" FT COMPBIAS 1344..1365 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 1533 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P55268" FT CARBOHYD 251 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 371 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1086 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1250 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1309 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1349 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1500 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 286..295 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 288..313 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 315..324 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 327..347 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 350..359 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 352..377 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 380..389 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 392..410 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 413..426 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 415..441 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 443..452 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 455..470 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 473..487 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 475..494 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 496..505 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 508..522 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 525..537 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 527..544 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 546..555 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 784..796 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 786..803 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 805..814 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 817..829 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 832..844 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 834..851 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 853..862 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 865..875 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 878..887 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 880..894 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 897..906 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 909..925 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 928..944 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 930..955 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 957..966 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 969..984 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 987..1001 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 989..1008 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1011..1020 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1023..1036 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1039..1059 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1041..1066 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1068..1077 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1080..1093 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1096..1108 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1098..1115 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1117..1126 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1129..1141 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1144..1156 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1146..1163 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1165..1174 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1177..1188 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1191 FT /note="Interchain" FT /evidence="ECO:0000305" FT DISULFID 1194 FT /note="Interchain" FT /evidence="ECO:0000305" FT DISULFID 1798 FT /note="Interchain" FT /evidence="ECO:0000305" FT CONFLICT 545 FT /note="R -> P (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 581 FT /note="G -> V (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 677 FT /note="F -> V (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 956 FT /note="Q -> H (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 959 FT /note="E -> A (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 973 FT /note="H -> P (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 1306 FT /note="L -> F (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 1449 FT /note="T -> P (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 1460 FT /note="T -> S (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 1487 FT /note="E -> A (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" FT CONFLICT 1627 FT /note="W -> R (in Ref. 1; AAC53535)" FT /evidence="ECO:0000305" SQ SEQUENCE 1799 AA; 196579 MW; 37CA24B9CDA0791F CRC64; MEWASGEPGR GRQGQPLPWE LRLGLLLSVL AATLAQAPSL DVPGCSRGSC YPATGDLLVG RADRLTASST CGLHSPQPYC IVSHLQDEKK CFLCDSRRPF SARDNPNSHR IQNVVTSFAP QRRTAWWQSE NGVPMVTIQL DLEAEFHFTH LIMTFKTFRP AAMLVERSAD FGRTWHVYRY FSYDCGADFP GIPLAPPRRW DDVVCESRYS EIEPSTEGEV IYRVLDPAIP IPDPYSSRIQ NLLKITNLRV NLTRLHTLGD NLLDPRREIR EKYYYALYEL VIRGNCFCYG HASQCAPAPG APAHAEGMVH GACICKHNTR GLNCEQCQDF YQDLPWHPAE DGHTHACRKC ECNGHTHSCH FDMAVYLASG NVSGGVCDGC QHNTAGRHCE FCRPFFYRDP TKDMRDPAVC RPCDCDPMGS QDGGRCDSHD DPVLGLVSGQ CRCKEHVVGT RCQQCRDGFF GLSASDPRGC QRCQCNSRGT VPGSSPCDSS SGTCFCKRLV TGHGCDRCLP GHWGLSHDLL GCRPCDCDVG GALDPQCDEA TGQCRCRQHM IGRRCEQVQP GYFRPFLDHL TWEAEAAQGQ GLEVVERLVT NRETPSWTGP GFVRLREGQE VEFLVTSLPR AMDYDLLLRW EPQVPEQWAE LELMVQRPGP VSAHSPCGHV LPKDDRIQGM LHPNTRFLVF PRPVCLEPGI SYKLKLKLIG TGGRAQPETS YSGLLIDSLV LQPHVLVLEM FSGGDAAALE RRTTFERYRC HEEGLMPSKA PLSETCAPLL ISVSALIYNG ALPCQCDPQG SLSSECSPHG GQCRCKPGVV GRRCDVCATG YYGFGPAGCQ ACQCSPDGAL SALCEGTSGQ CPCRPGAFGL RCDHCQRGQW GFPNCRPCVC NGRADECDTH TGACLGCRDY TGGEHCERCI AGFHGDPRLP YGGQCRPCPC PEGPGSQRHF ATSCHRDGYS QQIVCQCREG YTGLRCEACA PGHFGDPSKP GGRCQLCECS GNIDPMDPDA CDPHTGQCLR CLHNTEGPHC GYCKPGFHGQ AARQSCHRCT CNLLGTDPRR CPSTDLCHCD PSTGQCPCLP HVQGLNCDHC APNFWNFTSG RGCQPCACHP SRARGPTCNE FTGQCHCHAG FGGRTCSECQ ELYWGDPGLQ CRACDCDPRG IDKPQCHRST GHCSCRPGVS GVRCDQCARG FSGVFPACHP CHACFGDWDR VVQDLAARTR RLEQWAQELQ QTGVLGAFES SFLNMQGKLG MVQAIMSARN ASAASTAKLV EATEGLRHEI GKTTERLTQL EAELTAVQDE NFNANHALSG LERDGLALNL TLRQLDQHLE ILKHSNFLGA YDSIRHAHSQ STEAERRANA STFAVPSPVS NSADTRRRTE VLMGAQKENF NRQHLANQQA LGRLSAHAHT LSLTGINELV CGAPGDAPCA TSPCGGAGCR DEDGQPRCGG LGCSGAAATA DLALGRARHT QAELQRALVE GGGILSRVSE TRRQAEEAQQ RAQAALDKAN ASRGQVEQAN QELRELIQNV KDFLSQEGAD PDSIEMVATR VLDISIPASP EQIQRLASEI AERVRSLADV DTILAHTMGD VRRAEQLLQD AHRARSRAEG ERQKAETVQA ALEEAQRAQG AAQGAIWGAV VDTQNTEQTL QRVQERMAGA EKSLNSAGER ARQLDALLEA LKLKRAGNSL AASTAEETAG SAQSRAREAE KQLREQVGDQ YQTVRALAER KAEGVLAAQA RAEQLRDEAR DLLQAAQDKL QRLQELEGTY EENERALEGK AAQLDGLEAR MRSVLQAINL QVQIYNTCQ //